Dror Mevorach

8.4k citations
121 papers · 6.8k · 3 hit papers · h-index 34

Impact in

  • Rheumatology top 0.5%
    • Systemic Lupus Erythematosus Research
    • Rheumatoid Arthritis Research and Therapies
  • Immunology top 1%
    • Phagocytosis and Immune Regulation
    • Complement system in diseases
    • Immune Cell Function and Interaction

Papers in

    • Systemic Lupus Erythematosus Research 29
    • Phagocytosis and Immune Regulation 14
    • Complement system in diseases 10
    • Immune Cell Function and Interaction 5
    • Immunotherapy and Immune Responses 5

Dror Mevorach

119 papers receiving 6.5k citations

Dror Mevorach's Hit Papers

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial 2017 · 415 citations
4150+7+14Years since publication4008001.2k

Peers

Dror Mevorach
Comparison fields: 5 of 105
  • Rheumatology 1.4k
  • Immunology 1.9k
  • Genetics 671
  • Periodontics 297
  • Oncology 407
Replace Laura Maggi with:
Laura Maggi Italy
Paolo Casali United States
Veronica Santarlasci Italy
Shie-Liang Edmond Hsieh Taiwan
Thomas J. Lawley United States
Claudio Lunardi Italy
David A. Horwitz United States
Federica Calzetti Italy
Giorgio Senaldi United States
Noriko Sakaguchi Japan
Dror Mevorach relative to Laura Maggi Italy Laura Maggi's profile →
Citations per field
00.5×2×3.4×
Laura Maggi · 1×
Citations per year

Countries citing papers authored by Dror Mevorach

Since Specialization
Citations

This map shows the geographic impact of Dror Mevorach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dror Mevorach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dror Mevorach more than expected).

Fields of papers citing papers by Dror Mevorach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dror Mevorach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dror Mevorach. The network helps show where Dror Mevorach may publish in the future.

Co-authors

The 25 scholars most cited alongside Dror Mevorach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dror Mevorach Line = papers co-authored together Dror Mevorach links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell Attack
Hit paper breakdown →
20151215
2
Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness
Hit paper breakdown →
2004886
3 1998595
4 1998496
5
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial
Hit paper breakdown →
2017415
6 2005317
7 2002213
8 2012125
9 2006101
10 2017101
11 200994
12 200186
13 200678
14 200076
15 199575
16 201368
17 202264
18 200463
19 200961
20 201357

About Dror Mevorach

Dror Mevorach is a scholar working on Rheumatology, Immunology, Cardiology and Cardiovascular Medicine, Hematology and Infectious Diseases, having authored 121 papers that have together received 6.8k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (29 papers), Phagocytosis and Immune Regulation (14 papers), Complement system in diseases (10 papers), Viral Infections and Immunology Research (8 papers), Immune Cell Function and Interaction (5 papers), Immunotherapy and Immune Responses (5 papers), Cardiac electrophysiology and arrhythmias (4 papers) and COVID-19 Clinical Research Studies (4 papers). The work is most often cited by research in Rheumatology (1.4k citations), Immunology (1.9k citations), Genetics (671 citations), Periodontics (297 citations) and Oncology (407 citations). Dror Mevorach has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Keith B. Elkon, John O Mascarenhas, Xin Song, Jun Liang Zhou, Uriel Trahtemberg, Jacob Rachmilewitz, Eithan Galun, Hadi Aslan, Meir Liebergall and Shaul Beyth. Their work appears in journals such as Lupus, PLoS ONE, Blood, Annals of Pharmacotherapy and Journal of Clinical Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact